A study of Upsher-Smith Laboratories' Divigel (estradiol gel) 0.1% was presented at the Annual Meeting of the North American Menopause Society (NAMS). The study revealed that Divigel reduced the frequency and severity of moderate to severe hot flashed that come with menopause. Additional data found that Divigel is a safe, well-tolerate therapy that offers the lowest approved dosage of estradiol available.
"These data demonstrate that Divigel(R) is a safe and highly effective low dose therapy that quickly manages the uncomfortable side effects of menopause," said Dr. Ronald Ackerman, FACOG, CEO and principal investigator, Comprehensive Clinical Trials. "Women that have been reluctant to take older hormone therapies with higher doses of estrogen now have the choice of taking Divigel(R), the lowest dose of estradiol available."
Divigel is applied to the skin so that it can be absorbed directly into the bloodstream without passing through the liver and thus allows women to use a lower dosage of estrogen that would be needed with a pill.
Divigel, approved by the FDA in June 2007, is derived from plant sources and is identical to estrogen produced by women prior to menopause. It is a quick drying gel that is odorless and is available in a daily single use package.
Comment Preview